Emmanuel A. Ho

4.5k total citations · 1 hit paper
52 papers, 1.5k citations indexed

About

Emmanuel A. Ho is a scholar working on Molecular Biology, Microbiology and Pharmaceutical Science. According to data from OpenAlex, Emmanuel A. Ho has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Microbiology and 12 papers in Pharmaceutical Science. Recurrent topics in Emmanuel A. Ho's work include Advanced Drug Delivery Systems (11 papers), Reproductive tract infections research (10 papers) and RNA Interference and Gene Delivery (9 papers). Emmanuel A. Ho is often cited by papers focused on Advanced Drug Delivery Systems (11 papers), Reproductive tract infections research (10 papers) and RNA Interference and Gene Delivery (9 papers). Emmanuel A. Ho collaborates with scholars based in Canada, China and United States. Emmanuel A. Ho's co-authors include Derek Chen, Jin Wang, Micheline Piquette‐Miller, Jijin Gu, Yufei Chen, Christine Allen, Patrick Lim Soo, Song Liu, Seungil Kim and Carolyn L. Ren and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Emmanuel A. Ho

50 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Challenges in the development and establishment of exosome-based drug delivery systems

2020 288 citations Emmanuel A. Ho et al. Journal of Controlled Release profile →

Peers

Countries citing papers authored by Emmanuel A. Ho

Since Specialization

Citations

This map shows the geographic impact of Emmanuel A. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel A. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel A. Ho more than expected).

Fields of papers citing papers by Emmanuel A. Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel A. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel A. Ho. The network helps show where Emmanuel A. Ho may publish in the future.

Co-authorship network of co-authors of Emmanuel A. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel A. Ho. A scholar is included among the top collaborators of Emmanuel A. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel A. Ho. Emmanuel A. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ureasil-polyether hybrid polymer-based vaginal ovules for combination therapy in the treatment of vulvovaginal candidiasis 2025 ·Drug Delivery and Translational Research ·(unknown), (unknown), Chen Sun, (unknown), Emmanuel A. Ho, João Augusto Oshiro	1
2	Formulating biopharmaceuticals using three-dimensional printing 2024 ·Journal of Pharmacy & Pharmaceutical Sciences ·(unknown), (unknown), (unknown), Emmanuel A. Ho	3
3	Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders 2024 ·Drug Delivery and Translational Research ·Samiullah Khan, Chi Wai, Emmanuel A. Ho	1
4	Pneumolysin-responsive liposomal platform for selective treatment of Streptococcus pneumoniae 2024 ·Drug Delivery and Translational Research ·(unknown), (unknown), Emmanuel A. Ho	0
5	An insight on ophthalmic drug delivery systems: Focus on polymeric biomaterials-based carriers 2023 ·Journal of Controlled Release ·Muhammad Shafiq, Muhammad Rafique, (unknown), Pan Li, Chi Wai, Emmanuel A. Ho	36
6	Sustainable Materials for Fused Deposition Modeling 3D Printing Applications 2021 ·Advanced Engineering Materials ·(unknown), (unknown), Emmanuel A. Ho	53
7	Segmented intravaginal ring for the combination delivery of hydroxychloroquine and anti-CCR5 siRNA nanoparticles as a potential strategy for preventing HIV infection 2021 ·Drug Delivery and Translational Research ·(unknown), Yufei Chen, (unknown), Emmanuel A. Ho	3
8	Low-Dose Acetylsalicylic Acid Reduces T Cell Immune Activation: Potential Implications for HIV Prevention 2021 ·Frontiers in Immunology ·Julie Lajoie, (unknown), (unknown), Geneviève Boily-Larouche, Julius Oyugi, Yufei Chen, Makobu Kimani, Emmanuel A. Ho, Joshua Kimani, Keith R. Fowke	9
9	Microfluidic Technology for Antibacterial Resistance Study and Antibiotic Susceptibility Testing: Review and Perspective 2020 ·ACS Sensors ·Na Qin, Pei Zhao, Emmanuel A. Ho, Gongming Xin, Carolyn L. Ren	63
10	Autophagy induction and PDGFR-β knockdown by siRNA-encapsulated nanoparticles reduce chlamydia trachomatis infection 2019 ·Scientific Reports ·(unknown), (unknown), (unknown), Emmanuel A. Ho	27
11	Design and development of pH-responsive polyurethane membranes for intravaginal release of nanomedicines 2018 ·Acta Biomaterialia ·Seungil Kim, (unknown), Emmanuel A. Ho, Muhammad Shafiq, Soo Hyun Kim, Song Liu	34
12	Implant delivering hydroxychloroquine attenuates vaginal T lymphocyte activation and inflammation 2018 ·Journal of Controlled Release ·Yufei Chen, (unknown), (unknown), Julie Lajoie, Keith R. Fowke, Daniel W. Rickey, Emmanuel A. Ho	11
13	Dynamic mechanical behaviour of nanoparticle loaded biodegradable PVA films for vaginal drug delivery 2017 ·Journal of Biomaterials Applications ·(unknown), (unknown), Jijin Gu, Emmanuel A. Ho	18
14	A new strategy for battling bacterial resistance: Turning potent, non-selective and potentially non-resistance-inducing biocides into selective ones 2017 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), (unknown), Emmanuel A. Ho, Song Liu	12
15	Reversibly pH-responsive polyurethane membranes for on-demand intravaginal drug delivery 2016 ·Acta Biomaterialia ·Seungil Kim, Yufei Chen, Emmanuel A. Ho, Song Liu	37
16	Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine 2014 ·Drug Design Development and Therapy ·Emmanuel A. Ho, Yufei Chen, (unknown), Chun-Chun Li, Keith R. Fowke	26
17	Advancements in the field of intravaginal siRNA delivery 2013 ·Journal of Controlled Release ·(unknown), Yufei Chen, Roien Ahmadie, Emmanuel A. Ho	46
18	Characterization of Long-Circulating Cationic Nanoparticle Formulations Consisting of a Two-Stage PEGylation Step for the Delivery of siRNA in a Breast Cancer Tumor Model 2012 ·Journal of Pharmaceutical Sciences ·Emmanuel A. Ho, (unknown), (unknown), Dana Masin, Young Joo Yang, (unknown), Marcel B. Bally	26
19	Drug release mechanism of paclitaxel from a chitosan–lipid implant system: Effect of swelling, degradation and morphology 2007 ·European Journal of Pharmaceutics and Biopharmaceutics ·Patrick Lim Soo, Jaepyoung Cho, Justin Grant, Emmanuel A. Ho, Micheline Piquette‐Miller, Christine Allen	64
20	In vitro and in vivo characterization of a novel biocompatible polymer–lipid implant system for the sustained delivery of paclitaxel 2005 ·Journal of Controlled Release ·Emmanuel A. Ho, Vessela Vassileva, Christine Allen, Micheline Piquette‐Miller	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact